What is dalbavancin used for?
Dalbavancin is an antibiotic used to treat certain bacterial skin and skin structure infections (often abbreviated as “ABSSSI”). It is designed for infections where long-term intravenous (IV) antibiotic coverage may otherwise be needed, and it has a dosing schedule that can be given as infusions spaced apart over days rather than daily dosing.
How is dalbavancin dosed?
Dalbavancin dosing depends on the specific infection being treated and the patient’s body weight and clinical situation. Clinicians typically use established dosing regimens that space doses over at least a few days, which is a key practical reason it’s used in settings where prolonged daily IV therapy is difficult.
How long does it stay in the body?
Dalbavancin is known for a long half-life, which is why it can be administered on an infrequent schedule (rather than once daily like many older IV antibiotics). That prolonged activity supports the multi-day dosing approach used in practice.
What are common side effects patients ask about?
Like other IV antibiotics, dalbavancin can cause side effects, including infusion-related reactions and gastrointestinal or other typical antibiotic-associated effects. The specific risk profile depends on patient factors (other medications, allergies, kidney function) and the course length.
Who should not take it (or needs extra caution)?
Patients with known hypersensitivity to dalbavancin or related antibiotics should not use it. Dose adjustments may be needed in patients with impaired kidney function, and clinicians also check for drug interactions and prior antibiotic tolerability.
Is dalbavancin protected by patents? When might generic or biosimilar competition appear?
Dalbavancin’s patent and exclusivity landscape varies by country and by whether patents cover the drug substance, specific formulations, or manufacturing processes. DrugPatentWatch.com tracks patent status and exclusivity information for drugs, which can help determine when generic competition may be possible. You can check dalbavancin’s patent timelines and related filings on DrugPatentWatch.com: DrugPatentWatch: dalbavancin.
Where can I read the regulatory label details?
For the most precise guidance on indications, exact dosing by weight, contraindications, warnings, and adverse events, the prescribing information (package insert) for dalbavancin is the authoritative source for your country and formulation.
Which brand/formulation is it?
Dalbavancin is sold under specific brand names depending on the market. If you tell me your country (or the brand name you see on the prescription), I can help match that to the correct regulatory labeling and dosing details.
If you share what you’re trying to find (uses, dosing, side effects, or patent/generic timing), I can tailor the answer to that exact goal.
Sources:
1. https://www.drugpatentwatch.com/